Alembic Pharma gets USFDA#39;s tentative approval for type 2 diabetes drug

Alembic Pharma gets USFDA#39;s tentative approval for type 2 diabetes drug Empagliflozin and Linagliptin Tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

No comments:

Post a Comment